List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #901 to #950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. APLAUSEAnti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
  2. APL differentiation syndromeRetinoic acid syndrome
  3. APMLAcute promyelocytic leukemia
  4. APML differentiation syndromeRetinoic acid syndrome
  5. APO-AtenolAtenolol
  6. APO-GoApomorphine
  7. APO-Go PenApomorphine
  8. APOCARDImaging In Cardiac Transplant Patients
  9. APPIAmyloid precursor protein
  10. APPRAISE-1Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial
  11. APPROACHAssessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
  12. APRESAngiotensin-Converting Enzyme Inhibition Post Revascularization Study
  13. APRICOTAntithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
  14. APRICOT-2Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
  15. APS1Autoimmune polyendocrine syndrome
  16. APS 1Autoimmune polyendocrine syndrome
  17. APS type 1Autoimmune polyendocrine syndrome
  18. APS type 2Autoimmune polyendocrine syndrome
  19. APS type 3Autoimmune polyendocrine syndrome
  20. APTAmiodarone pulmonary toxicity
  21. APTTPartial thromboplastin time
  22. APTXAprataxin
  23. APUDoma of skinMerkel cell cancer
  24. APUDoma of the skinMerkel cell cancer
  25. AP endonucleasesAP endonuclease
  26. AQP1Aquaporin 1
  27. ARAortic regurgitation
  28. AR-CMT2Charcot-Marie-Tooth Syndrome
  29. ARBAngiotensin II receptor antagonist
  30. ARBITER 2Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2
  31. ARBsAngiotensin II receptor antagonist
  32. ARCHAmiodarone Reduction In Coronary Heart Trial
  33. ARCHeRFor Revascularization Of Carotids In High-Risk Patients
  34. ARDSAcute respiratory distress syndrome
  35. AREDSAge-Related Eye Disease Study
  36. ARFAcute kidney injury
  37. ARG-911Argatroban-911
  38. ARG-915Argatroban-915
  39. ARGAMI-2Argatroban For Acute Myocardial Infarction
  40. ARICAtherosclerosis Risk In Communities
  41. ARIES 1 and 2Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
  42. ARISEAggressive Reduction Of Inflammation Stops Events
  43. ARI Sodium Iodide (I123) 1-12 MBqSodium iodide
  44. ARI Sodium Iodide (I123) 100-750 MBqSodium iodide
  45. ARMSApsac Reocclusion Multicenter Study
  46. ARMYDAAtorvastatin For Reduction Of Myocardial Damage During Angioplasty
  47. ARMYDA-2Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
  48. ARMYDA-3Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
  49. ARMYDA-4Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
  50. ARMYDA-5Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5

View ( | ) (20 | 50 | 100 | 250 | 500)